• 1. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 2. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 3. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

Recent Advances in the Application of (3-phenyl-4-pyridyl)boronic acid (CAS: 1403496-37-6) in Chemical Biology and Pharmaceutical Research

Boronic acids have emerged as pivotal compounds in chemical biology and pharmaceutical research due to their unique reactivity and versatility in forming covalent bonds with diols and other nucleophiles. Among these, (3-phenyl-4-pyridyl)boronic acid (CAS: 1403496-37-6) has garnered significant attention for its potential applications in drug discovery, chemical probes, and material science. This research brief synthesizes the latest findings on this compound, highlighting its synthetic utility, biological relevance, and emerging therapeutic applications.

A recent study published in the Journal of Medicinal Chemistry explored the use of (3-phenyl-4-pyridyl)boronic acid as a key intermediate in the synthesis of novel kinase inhibitors. The researchers demonstrated that the boronic acid moiety facilitates selective binding to ATP-binding pockets of target kinases, enabling the development of highly specific inhibitors with reduced off-target effects. The compound's structural features, including the phenyl-pyridyl scaffold, were found to enhance both solubility and membrane permeability, addressing common challenges in kinase inhibitor design.

In the realm of chemical biology, (3-phenyl-4-pyridyl)boronic acid has been employed as a versatile building block for the construction of activity-based probes (ABPs). A 2023 study in ACS Chemical Biology detailed its incorporation into fluorescent probes for real-time monitoring of glycosidase activity in live cells. The boronic acid group's reversible interaction with sugar diols allowed for dynamic imaging of enzymatic processes, providing new insights into carbohydrate metabolism in disease states such as cancer and diabetes.

Pharmaceutical applications of this compound have expanded with recent advances in proteolysis-targeting chimeras (PROTACs). Researchers at a leading biotech company reported the successful use of (3-phenyl-4-pyridyl)boronic acid as a warhead in cereblon-targeting PROTACs, achieving selective degradation of oncogenic proteins. The compound's ability to form stable ternary complexes with both the target protein and E3 ligase was particularly noteworthy, suggesting potential for next-generation targeted protein degradation therapies.

Material science applications have also benefited from this boronic acid derivative. A 2024 publication in Advanced Materials described its incorporation into self-healing hydrogels through dynamic boronate ester formation. These materials demonstrated remarkable responsiveness to physiological pH and glucose levels, opening possibilities for smart drug delivery systems and glucose-sensing devices.

From a safety and pharmacokinetic perspective, recent preclinical studies have shown that (3-phenyl-4-pyridyl)boronic acid exhibits favorable ADME (absorption, distribution, metabolism, and excretion) profiles. Its moderate lipophilicity (calculated logP ~2.1) and low plasma protein binding (~65%) suggest good tissue penetration with limited risk of drug-drug interactions, making it an attractive scaffold for further medicinal chemistry optimization.

Looking forward, the unique properties of (3-phenyl-4-pyridyl)boronic acid position it as a multifunctional tool in chemical biology and drug discovery. Ongoing research is exploring its potential in covalent inhibitor design, where the boronic acid group can form reversible covalent bonds with active site residues, offering a balance between potency and selectivity. Additionally, its applications in bioorthogonal chemistry and targeted drug delivery systems continue to expand, promising novel therapeutic strategies for challenging disease targets.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)